Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, MISCELLANEOUS

The Right to Be Treated: Overcoming Bias & Discrimination in Obesity Care


WINNIPEG, Manitoba, Oct. 03, 2018 (GLOBE NEWSWIRE) --

Who: Reporters and editors covering health, wellness, diet, exercise, healthcare delivery, human rights and politics. 

What: To mark impending legislation aimed at protecting size and weight under human rights laws, this public event features experts from Obesity Canada discussing the negative impacts that weight-based bias and discrimination has on access to healthcare (as well as equity in school, the media, at home and in the workplace). Topics will include:

Speakers:
Dr. Arya M. Sharma, Scientific Director, Obesity Canada and Professor, University of Alberta
Mary Forhan, PhD, Assistant Professor, Rehabilitation Medicine, University of Alberta
Ian Patton, PhD, Public Engagement Coordinator, Obesity Canada and patient advocate representing the lived experience of obesity

When: October 15, 2018, 6:30 - 8:30pm

Where: Canadian Museum for Human Rights, 85 Israel Asper Way, Winnipeg, MB R3C 0L5

Public Admission: $5.00, register via https://obesitycanada.ca/con-events/the-right-to-be-treated-overcoming-bias-discrimination-in-obesity-care/

Pre-Event Interview Opportunities:
Dr. Sharma and Dr. Patton: 8:00 a.m. to 11:30 a.m. October 15, 2018
Dr. Forhan: 10:00 a.m to 11:30 a.m. October 15, 2018
Varying ability prior to the 15th

To arrange interviews prior to October 15th contact:
Brad Hussey, Director of Communications, Obesity Canada
[email protected]
905-628-7778

To arrange interviews on October 15th, contact:
Ian Patton, Public Engagement Coordinator, Obesity Canada
[email protected]
289-927-5576


These press releases may also interest you

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...



News published on and distributed by: